Additionally, IL-1β blockade has also been used for other indications in patients with VEO-IBD, including as bridge to hematopoietic stem cell transplantation in patients with IL10 signaling defects, chronic granulomatous disease (CGD) resulting in phagocyte abnormalities and T regulatory defects (17), among others. This evidence concerns the gene IL1B and inflammatory bowel disease.